Search enhanced by Google
Shuai Chen, Ph.D.
Associate Professor, Division of Biostatistics
Locations and Contact
Research/Academic Interests
As a biostatistician, Dr. Chen's primary methodological research interests are in cost-effectiveness analysis with censored data, personalized treatment, survival analysis, longitudinal data analysis, and causal inference, as well as their applications in various pre-clinical and clinical studies. She has broad collaborative experience in various health-related area such as cancer, liver disease, mental health, chronic diseases, and health services.
Division
Biostatistics
Center/Program Affiliation
Undergraduate School
B.S., Peking University, Beijing, China 2010
Other School
M.S., Statistics, Texas A&M University, College Station TX 2012
Other School
Ph.D., Statistics, Texas A&M University, College Station TX 2015
Susan B. Anthony Aetna Award for Excellence in Research on Older Women and Public Health, 141st Annual Meeting of the American Public Health Association (Authorship: Smith, Jiang, Prizer, Ahn, Chen, Cho, Graham, Ory)., 2013
To view a detailed list of Dr. Chen's publications, please click here.
Kerlikowske K, Chen S, Bissell M, Lee CI, Tice J, Sprague BL, Miglioretti DL. Population Attributable Risk of Advanced Stage Breast Cancer by Race and Ethnicity, JAMA Oncology. 2024; 10(2), 167–175.
Monjazeb AM, Daly ME, Luxardi G, Maverakis E, Merleev A, Marusina A, Borowsky A, Mirhadi A, Shiao SL, Beckett L, Chen S, Eastham D, Li T, Vick LV, McGee HM, Lara F, Garcia L, Morris LA, Canter RJ, Riess JW, Schalper KA, Murphy WJ, Kelly K. Atezolizumab plus Stereotactic Ablative Radiotherapy for Medically Inoperable Patients with Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Phase I trial, Nature Communications. 2023; 14(1), 5332.
Sprague BL, Chen S, Miglioretti DL, Gard CC, Tice JA, Hubbard RA, Bowles EJA, Kaufman PA, Kerlikowske K. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency, JAMA Network Open. 2023; 6(2), e230166.
Chen S, Hoch JS. Net-benefit regression with censored cost-effectiveness data from randomized or observational studies, Statistics in Medicine. 2022; 41(20), 3958-3974.
Kerlikowske K, Chen S, Golmakani MK, Sprague BL, Tice JA, Tosteson ANA, Rauscher GH, Henderson LM, Buist DSM, Lee JM, Gard CC, Miglioretti DL. Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population, Journal of the National Cancer Institute. 2022; 114(5), 676-685.
Liu AT, Chen S, Jena PK, Sheng L, Hu Y, Wan YY. Probiotics Improve Gastrointestinal Function and Life Quality in Pregnancy, Nutrients. 2021; 13(11), 3931.
Chen S, Tian L, Cai T, and Yu M. A General Statistical Framework for Subgroup Identification and Comparative Treatment Scoring, Biometrics. 2017; 73(4),1199-1209.
Brower JV, Amini A, Chen S, Hullett CR, Kimple RJ, Bassetti M, Witek ME, Yu M, and Baschnagel AM. Improved Survival with Dose Escalated Radiotherapy in Stage III Non-small Cell Lung Cancer, Analysis of the National Cancer Database, Annals of Oncology. 2016; 27(10), 1887-1894.
Chen S, Rolfes J, and Zhao H. Estimation of Mean Health Care Costs and Incremental Cost-effectiveness Ratios with Possibly Censored Data, The Stata Journal. 2015; 15(3), 698-711.
Chen S, Zhao H. Estimating Incremental Cost-Effectiveness Ratios and Their Confidence Intervals with Different Terminating Events for Survival Time and Costs, Biostatistics. 2013; 14(3), 422-432.